Product Information

FENOFIBRATE 160 MG TABLET is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.0914 per EA under NDC 42858066045. Its NADAC has been published 489 times since Jul 12, 2017.

FDA first approved this application on May 13, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FENOFIBRATE 160 MG TABLET

Fenofibrate
$0.0914per EA

Strength

160 mg/1

NDC

42858066045

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

FENOFIBRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA076433

FDA Approved

5/13/2005

TE Code

AB

On Market Since

6/1/2017

Price Statistics

The NADAC for FENOFIBRATE 160 MG TABLET has been published 489 times since Jul 12, 2017, and over the history we have for it it has declined 81.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0914 per EA
All-time high$0.4937 (Jul 12, 2017)
All-time low$0.0892 (Dec 17, 2025)
52-week high$0.1259
52-week low$0.0892
Median price$0.1881
Average price$0.2173
Largest weekly change+41.1% (Jan 17, 2024)
Weeks tracked489
Tracking sinceJul 12, 2017

Price History

1W

-1.3%

1M

-11.6%

3M

-19.1%

6M

-26.3%

1Y

-17.8%

3Y

-39.2%

5Y

-61.5%

All

-81.5%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FENOFIBRATE 160 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 160 MG TABLET, manufactured by Rhodes Pharmaceuticals L.P., is $0.0914 per EA (NDC 42858066045), effective Nov 18, 2026.

How has the price of FENOFIBRATE 160 MG TABLET changed over time?

Over the history we have for it, the NADAC for FENOFIBRATE 160 MG TABLET has declined 81.5%. It has been tracked across 489 weekly CMS publications since Jul 12, 2017.

What are the highest and lowest recorded NADAC prices for FENOFIBRATE 160 MG TABLET?

Since Jul 12, 2017, the NADAC for FENOFIBRATE 160 MG TABLET has ranged from a low of $0.0892 (Dec 17, 2025) to a high of $0.4937 (Jul 12, 2017), with a median of $0.1881 per EA.

Are there cheaper alternatives to FENOFIBRATE 160 MG TABLET?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FENOFIBRATE 160 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures FENOFIBRATE 160 MG TABLET?

FENOFIBRATE 160 MG TABLET (NDC 42858066045) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.